Carmen Guillen-Ponce

Summary

Affiliation: Hospital Universitario
Country: Spain

Publications

  1. doi request reprint Follow-up recommendations and risk-reduction initiatives for Lynch syndrome
    Carmen Guillen-Ponce
    Medical Oncology Department, Hospital Universitario Ramon y Cajal, Madrid, Spain
    Expert Rev Anticancer Ther 12:1359-67. 2012
  2. pmc The Int7G24A variant of transforming growth factor-beta receptor type I is a risk factor for colorectal cancer in the male Spanish population: a case-control study
    Adela Castillejo
    Molecular Oncology Group, Elche University Hospital, Camino Almazara 11, 03203 Elche, Spain
    BMC Cancer 9:406. 2009
  3. pmc The TGFBR1*6A allele is not associated with susceptibility to colorectal cancer in a Spanish population: a case-control study
    Adela Castillejo
    Molecular Oncology Group, Elche University Hospital, Camino Almazara 11, Elche, Spain
    BMC Cancer 9:193. 2009
  4. ncbi request reprint Panhypopituitarism as first manifestation of a lung cancer
    Carmen Guillen Ponce
    Servicio de Oncologia Medica, Hospital General Universitario de Elche, Alicante, Spain
    Clin Transl Oncol 9:53-5. 2007
  5. ncbi request reprint A patient with breast cancer with hepatic metastases and a complete response to herceptin as monotherapy
    Sonia Macia Escalante
    Department of Medical Oncology, Elche University General Hospital, Eche, Alicante, Spain
    Clin Transl Oncol 8:761-3. 2006
  6. ncbi request reprint Cushing's paraneoplastic syndrome as first manifestation of an adenocarcinoma of unknown origin
    María José Molina Garrido
    Servicio de Oncologia Medica, Hospital General Universitario de Elche, Alicante, Spain
    Clin Transl Oncol 8:621-3. 2006
  7. ncbi request reprint Skin metastases as first manifestation of lung cancer
    María José Molina Garrido
    Servicio de Oncologia Medica, Hospital General Universitario de Elche, Alicante, Spain
    Clin Transl Oncol 8:616-7. 2006
  8. doi request reprint Biallelic MYH germline mutations as cause of Muir-Torre syndrome
    Carmen Guillen-Ponce
    Medical Oncology Department, Ramon y Cajal University Hospital, Carretera de Colmenar, Km 9, 100, 28034, Madrid, Spain
    Fam Cancer 9:151-4. 2010
  9. ncbi request reprint Recurrent pericardial effusion as initial manifestation of primary diffuse pericardial malignant mesothelioma
    María José Molina Garrido
    Department of Oncology, General Universitary Hospital from Elche, Alicante, Spain
    Clin Transl Oncol 8:694-6. 2006
  10. doi request reprint Understanding the molecular-based mechanism of action of the tyrosine kinase inhibitor: sunitinib
    Alfredo Carrato Mena
    Medical Oncology Department, Universitary Hospital Ramon y Cajal, Madrid, Spain
    Anticancer Drugs 21:S3-11. 2010

Collaborators

  • Alfredo Carrato
  • María José Molina-Garrido
  • Javier Gallego-Plazas
  • Adela Castillejo
  • María José Molina Garrido
  • Alfredo Carrato Mena
  • Carmen Guillen Ponce
  • Sonia Macia Escalante
  • Noemi Garrigós
  • Alvaro Rodriguez-Lescure
  • Vanesa Pons Sanz
  • Antonia Mora Rufete
  • Enrique Grande Pulido
  • Miriam García-Bautista
  • José L Soto
  • Angeles Gómez-Martínez
  • Patricia Guaraz
  • Javier Gallego
  • María Pilar Garrido López
  • Gema Muñoz Molina
  • Natividad Martinez Banaclocha
  • Alvaro Rodriguez Lescure
  • José Domingo Cascón Pérez
  • Francisco Ardoy
  • Maria José Martínez Ortiz
  • Inmaculada Ballester Navarro

Detail Information

Publications13

  1. doi request reprint Follow-up recommendations and risk-reduction initiatives for Lynch syndrome
    Carmen Guillen-Ponce
    Medical Oncology Department, Hospital Universitario Ramon y Cajal, Madrid, Spain
    Expert Rev Anticancer Ther 12:1359-67. 2012
    ..Furthermore, the clinical and biological characteristics of this disease and their potential impact on prevention in individuals at risk are analyzed...
  2. pmc The Int7G24A variant of transforming growth factor-beta receptor type I is a risk factor for colorectal cancer in the male Spanish population: a case-control study
    Adela Castillejo
    Molecular Oncology Group, Elche University Hospital, Camino Almazara 11, 03203 Elche, Spain
    BMC Cancer 9:406. 2009
    ..Its role in colorectal cancer (CRC) has not been established. The aims of this study were to assess the association of TGFBR1*Int7G24A variant with CRC occurrence, patient age, gender, tumour location and stage...
  3. pmc The TGFBR1*6A allele is not associated with susceptibility to colorectal cancer in a Spanish population: a case-control study
    Adela Castillejo
    Molecular Oncology Group, Elche University Hospital, Camino Almazara 11, Elche, Spain
    BMC Cancer 9:193. 2009
    ..The aim of this study was to assess the association between TGFBR1*6A and colorectal cancer, age, sex, tumour location and tumour stage in a Spanish population...
  4. ncbi request reprint Panhypopituitarism as first manifestation of a lung cancer
    Carmen Guillen Ponce
    Servicio de Oncologia Medica, Hospital General Universitario de Elche, Alicante, Spain
    Clin Transl Oncol 9:53-5. 2007
    ..Magnetic resonance imaging revealed a large sellar mass, with clivus infiltration and invading the right cavernous sinus. The biopsy result was adenocarcinoma metastases from lung cancer...
  5. ncbi request reprint A patient with breast cancer with hepatic metastases and a complete response to herceptin as monotherapy
    Sonia Macia Escalante
    Department of Medical Oncology, Elche University General Hospital, Eche, Alicante, Spain
    Clin Transl Oncol 8:761-3. 2006
    ..Trastuzumab has revolutionised the management of patients with metastatic breast cancer and Her-2- neu overexpression. Its combination with chemotherapy agents achieves a synergic activity...
  6. ncbi request reprint Cushing's paraneoplastic syndrome as first manifestation of an adenocarcinoma of unknown origin
    María José Molina Garrido
    Servicio de Oncologia Medica, Hospital General Universitario de Elche, Alicante, Spain
    Clin Transl Oncol 8:621-3. 2006
    ..We hereby present the case of a patient diagnosed with a metastatic carcinoma of unknown origin associated with two paraneoplastic syndromes: a Cushing's syndrome and a sensitive-motor axonal neuropathy, a very uncommon association...
  7. ncbi request reprint Skin metastases as first manifestation of lung cancer
    María José Molina Garrido
    Servicio de Oncologia Medica, Hospital General Universitario de Elche, Alicante, Spain
    Clin Transl Oncol 8:616-7. 2006
    ..Sometimes, the study of the extent in the patients reveals that there are no metastases at other levels. We hereby present the case of a male diagnosed with a lung cancer whose first manifestation was the appearance of skin metastases...
  8. doi request reprint Biallelic MYH germline mutations as cause of Muir-Torre syndrome
    Carmen Guillen-Ponce
    Medical Oncology Department, Ramon y Cajal University Hospital, Carretera de Colmenar, Km 9, 100, 28034, Madrid, Spain
    Fam Cancer 9:151-4. 2010
    ..Furthermore, this report contributes to characterize the clinical phenotype caused by biallelic mutations in MYH gene, which may share with other hereditary colon cancer syndromes...
  9. ncbi request reprint Recurrent pericardial effusion as initial manifestation of primary diffuse pericardial malignant mesothelioma
    María José Molina Garrido
    Department of Oncology, General Universitary Hospital from Elche, Alicante, Spain
    Clin Transl Oncol 8:694-6. 2006
    ..Diffuse malignant pericardial mesothelioma was diagnosed after mediastinal mass biopsy. The patient underwent further oncological evaluation followed by chemotherapy...
  10. doi request reprint Understanding the molecular-based mechanism of action of the tyrosine kinase inhibitor: sunitinib
    Alfredo Carrato Mena
    Medical Oncology Department, Universitary Hospital Ramon y Cajal, Madrid, Spain
    Anticancer Drugs 21:S3-11. 2010
    ..Ongoing studies will elucidate the overall role of this drug in cancer treatment...
  11. ncbi request reprint Adjuvant therapy of resected gastric cancer is necessary
    Alfredo Carrato
    Medical Oncology Service, Elche University Hospital, 03202 Elche, Alicante, Spain
    Semin Oncol 32:S105-8. 2005
    ..New target-oriented agents, as well as tailored therapy based on the molecular profile of both the tumor and the patient, might also contribute to improved results...
  12. doi request reprint Circulating tumour cell analysis as an early marker for relapse in stage II and III colorectal cancer patients: a pilot study
    Noemi Garrigós
    Elche University Hospital, Elche, Alicante, Spain
    Clin Transl Oncol 12:142-7. 2010
    ..Recent studies have identified both the prognostic and predictive utility of determining the number of circulating tumour cells (CTC) in patients with solid cancers...
  13. ncbi request reprint [Ophthalmoplegia in a patient with prostate cancer and bone metastases]
    Sonia Macia Escalante
    Servicio de Oncologia Medica, Hospital General Universitario de Elche, Camí de L Almazara 11, 03203 Elche, Alicante, Spain
    Clin Transl Oncol 7:414-6. 2005
    ..Measurements of circulating levels of prostate specific antigen and prostate acid phosphatase are very useful in the clinical diagnosis of the primary tumour, or its metastases...